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ABSTRACT: The binding of several different active site mutants of Bacillus circulans cyclodextrin
glycosyltransferase to the inhibitor acarbose has been investigated through measurement of Ki values.
The mutations represent several key amino acid positions, most of which are believed to play important
roles in governing the product specificity of cyclodextrin glycosyltransferase. Michaelis-Menten
parameters for the substrates R-maltotriosyl fluoride (RG3F) and R-glucosyl fluoride (RGF) with each
mutant have been determined by following the enzyme-catalyzed release of fluoride with an ion-selective
fluoride electrode. In both cases, reasonable correlations are observed in logarithmic plots relating the Ki
value for acarbose with each mutant and both kcat/Km and Km for the hydrolysis of either substrate by the
corresponding mutants. This indicates that acarbose, as an inhibitor, is mimicking aspects of both the
ground state and the transition state. A better correlation is observed for RGF (r ) 0.98) than RG3F (r
) 0.90), which can be explained in terms of the modes of binding of these substrates and acarbose.
Re-refinement of the previously determined crystal structure of wild-type CGTase complexed with acarbose
[Strokopytov, B., Penninga, D., Rozeboom, H. J., Kalk, K. H., Dijhuizen, L., and Dijkstra, B. W. (1995)
Biochemistry 34, 2234-2240] reveals a binding mode consistent with the transition state analogue character
of this inhibitor.
Transition state analogues have long provided a valuable
tool for probing enzymatic mechanisms as well as providing
a basis for the design of tight binding enzyme inhibitors.
Their design is based on the principle that extra binding
interactions develop between the enzyme and substrate in
the transition state complex conferring reaction specificity
and rate acceleration. Thus, analogues which mimic the
substrate transition state structure should bind tightly. This
transition state analogy, which was first proposed by Pauling
in 1946 (2) and then further evolved by Lienhard (3) and
Wolfenden (4), has provided the framework for the design
of a wide variety of tight binding, reversible enzyme
inhibitors. Key characteristics of sugar-based transition state
analogue inhibitors for glycosidases are a positive charge, a
trigonal anomeric center, and a half-chair-like conformation
(5-8).
A useful way of determining whether a particular inhibitor
is truly a transition state analogue or is just a fortuitously
tight binding inhibitor involves probing the effects on the
Ki value of modifications to the interactions between the
enzyme and inhibitor and then probing the effects of
equivalent modifications to the enzyme/substrate complex
at the transition state, as revealed in kcat/Km values. If the
effects on the inhibitor Ki value correlate well with the effects
on substrate kcat/Km, then it can be concluded that the inhibitor
is indeed a transition state analogue. This approach has been
reviewed recently (9). Such modifications can be effected
in two ways. One way involves the synthesis and kinetic
evaluation of a series of modified substrates with the wild-
type enzyme, along with measurement of Ki values for the
identically modified inhibitors. The other approach involves
the construction of a series of mutant enzymes, preferably
mutated at sites thought to play a role in substrate recognition
and catalysis, and then measurement of kcat/Km and Ki values
with each mutant for a single substrate and transition state
analogue inhibitor, respectively. The choice of approach
depends primarily upon whether it is easier to generate
mutant enzymes or modified substrates and inhibitors. The
former approach has been used to demonstrate that a series
of phosphonamidate peptide derivatives are indeed true
transition state analogue inhibitors for zinc peptidases and
thermolysin (10-12). Similarly, nojiritetrazoles were shown
by this method to be true transition state analogues for a
range of glycosidases (7). Using the same approach,
1-deoxynojirimycin and castanospermine were shown not to
be transition state analogues for Agrobacterium sp. â-glu-
cosidase but rather, tight binding fortuitous inhibitors (13).
The latter approach has been applied to rat carboxypeptidase
A( 12, 14) and glucoamylase (15). It seemed possible that
such an approach could be applied to interactions of the
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Published on Web 11/13/1998enzyme cyclodextrin glycosyltransferase (CGTase)1 with the
inhibitor acarbose to further understand the binding mode
of acarbose to CGTase observed crystallographically (16).
CGTases are glycosyl transferases that degrade starch into
linear or cyclic oligosaccharides (cyclodextrins). Much
attention has been paid to these enzymes for their value in
producing cyclodextrins, which have wide industrial ap-
plications (17). However, most CGTases suffer from a low
product specificity, resulting in mixtures of most commonly
R-, â- and ç-cyclodextrins which then require costly crystal-
lization procedures for purification (18). Therefore, a great
deal of effort has been expended to design CGTases with
unique product specificities by generation of a number of
mutants modified in the active site (19, 20). These enzymes
belong to the same sequence- and structure-related family
[Family 13; a (â/R)8 barrel] as do R-amylases and many
R-glucosidases. As such, they are inhibited by the natural
product acarbose, a pseudotetrasaccharide isolated from
Actinoplanes, which has long been known as a potent
reversible inhibitor of many Family 13 enzymes including
the pig pancreatic R-amylase (Ki ) 10 íM) (21), as well as
of the Family 15 glucoamylase (Ki ) 0.1 nM) (22) (Figure
1). Indeed, it is currently used as a drug for the control of
blood glucose levels in diabetics (23-25). Recently, the 2.5
Å crystal structure of a CGTase with acarbose bound at the
active site was reported (16) as well as a structure of CGTase
with a bound maltononaose inhibitor apparently derived from
condensation of maltopentaose and acarbose (26). Interest-
ingly, the mode of binding of acarbose appeared to be
different from that in previously reported structures of
complexes of acarbose with other R-glycosyl transferases/
hydrolases, namely, glucoamylase, porcine pancreatic R-amy-
lase, Aspergillus oryzae R-amylase (27-29), and a thermo-
stable CGTase (30) since the valienamine moiety, generally
thought to mimic the glycosyl cation-like transition state,
does not appear to be bound in the -1 site in the case of
CGTase.2 Rather, it was interpreted to be bound in the -2
site, with the 6-deoxyglycosyl moiety bound in the -1 site
and its glycosidic oxygen at the site of cleavage.
In an effort to investigate the interactions of acarbose with
CGTase, we have screened a range of active site mutants
which are believed to be responsible for governing a wide
range of product specificities (Figure 2). Two substrates,
R-maltotriosyl fluoride (RG3F) and R-glucosyl fluoride
(RGF), were used in this analysis, allowing the determination
of accurate kinetic parameters in a direct assay monitoring
fluoride ion release (31). By correlating the kinetic param-
eters so determined with Ki values for acarbose, insights have
been obtained into the nature of the strong inhibition afforded
by this naturally occurring and therapeutically important
inhibitor. In addition, to investigate whether an alternative
binding mode of acarbose would be compatible with the
original data set, the structure was re-refined.
MATERIALS AND METHODS
General. All mutant CGTases were generated and purified
as previously reported (32). RG3F and RGF were synthe-
sized by the method of Junnemann et al. (33). All other
chemicals were purchased from Sigma Chemical Co. with
the exception of acarbose which was generously provided
by Miles Inc. (now Bayer).
Kinetic Analysis. (A) Glycosyl Fluorides. The enzyme-
catalyzed reactions were followed by monitoring the release
of fluoride using an Orion fluoride-selective electrode
interfaced to a pH/ion selective meter (Fischer Scientific).
Data were collected using the program Terminal and
analyzed using the program Grafit (34). In a typical
experiment, RG3F or RGF was preincubated in 100 mM
citrate buffer, pH 6.0, at 30 °C, for 10 min. The reaction
was initiated by adding an appropriately diluted aliquot of
enzyme in citrate buffer [final enzyme concentration with
RG3F as substrate: wild-type (0.25 íg/mL); S145E (1.1 íg/
1 Abbreviations: CGTase, cyclodextrin glycosyltransferase; RG3F,
R-maltotriosyl fluoride; RGF, R-glucosyl fluoride; G, glucose; G2,
maltose; G3, maltotriose; G4, maltotetraose; G5, maltopentaose; G6,
maltohexaose; wt, wild-type.
2 We are using the universal subsite nomenclature system recently
proposed (1) in which cleavage occurs between the -1 and +1 subsites.
FIGURE 1: Structure of the pseudotetrasaccharide acarbose posi-
tioned in the subsites of CGTase in the ‘amylase’ mode with the
relative binding positions of RG3F and RGF shown above. The
cleavage site is positioned between subsites -1 and +1.
FIGURE 2: Active site of CGTase modeled with maltononaose
bound showing the relative positions of the amino acid residues.
[Diagram modeled on the crystal structure of a Y195F mutant
complexed with an acarbose-derived maltononaose inhibitor (26)].
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íg/mL); N326Q (3.2 íg/mL); Y195G (3.2 íg/mL); Y195F
(1.1 íg/mL); Y195L (1.1 íg/mL); with RGF as substrate:
wild-type (0.25 íg/mL); S145E (19.3 íg/mL); S146P (416
íg/mL); D371N (97.3 íg/mL); N193G (65 íg/mL); N326Q
(254 íg/mL); Y195G (276 íg/mL); Y195F (16.6 íg/mL);
Y195L (28.1 íg/mL)] and the progress of the reaction
monitored for approximately 5-10 min or until a maximum
of 10% of substrate was consumed. For each enzyme, a
total of seven substrate concentrations were analyzed, ranging
from 0.2 to 5 times Km. In almost all cases the kinetic
constants Km, Vmax, and kcat were calculated from a fit to the
Michaelis-Menten equation using the program GraFit (34).
For those mutants with very high Km values (Y195G and
N326Q), thus for which saturation behavior could not be
observed, an accurate value of kcat/Km was obtained from
the slope of the Lineweaver-Burk plot, and very ap-
proximate estimates of the individual parameters were
obtained from the intercepts.
(B) EValuation of Oligosaccharides as Acceptors. Dif-
ferences in rate upon the addition of various maltooligosac-
charide acceptors were determined by measuring the initial
rate of D371N CGTase (10 íL aliquot, final concentration
was 97.3 íg/mL) catalyzed fluoride release using a single
concentration of RGF (40 íL aliquot, final concentration was
28 mM) in 100 mM citrate buffer, pH 6.0 (final volume
before the addition of oligosaccharide was 260 íL). After
following the reaction for 2 min, a 20 íL aliquot of the
appropriate acceptor was added and the progress of the
reaction monitored. Final concentrations of G to G6 were
30 mM.
(C) Inhibition of CGTases by Acarbose. Approximate Ki
values for acarbose with each mutant were first determined
by measuring the rate of enzyme-catalyzed fluoride release
for a single concentration of RG3F or RGF at each of a series
of concentrations of acarbose (6-8 concentrations), bracket-
ing the Ki value so determined. The enzyme concentrations
were identical to those used above for the respective
substrate. The observed rates were plotted in the form of a
Dixon plot (1/V vs [acarbose]), and the Ki value was
determined (assuming competitive inhibition) from the
intercept of this line with the horizontal line drawn through
1/Vmax. In our experience, this approach consistently pro-
vides a Ki value close (within 20%) to that ultimately
measured by a full analysis. Full Ki determinations were
performed by measurements of Vmax and Km values at a series
of inhibitor concentrations (typically five concentrations)
which bracket the Ki value to be determined. The value of
Ki and the mode of inhibition were determined through a
direct fit of the data to expressions for each inhibition mode
using the program GraFit (34).
Crystallographic Refinement. The CGTase-acarbose
structure (cgtaca, PDB id code: 1cxg) was re-refined against
the old data. To guard against overfitting, the free R-factor
technique (35) was used, which was not available at the time
the initial structure was refined. The structure of the CGTase
mutant N193G (J. Uitdehaag, unpublished), without any
ligands or waters, was taken as the starting model, because
its cell parameters best resembled those of the cgtaca data
set (16), with the same indices as the free R-factor set used
for the N193G refinement, comprising 2248 reflections out
of the total of 23 325.
For the actual refinement, the program TNT (36) was used
in combination with O (37). The overall procedure for
CGTase has been outlined previously (30). The number of
refinable parameters was reduced by including only a few
solvent oxygens, and keeping very tight restraints on the
stereochemistry, which limits the degrees of freedom of
bound atoms. At the beginning, the new initial structure had
an R-factor of 34.0% and a free R-factor of 34.4%. In the
course of refinement, and after model rebuilding (see below),
this decreased to a final R-factor of 18.2% and a final free
R-factor of 23.7%. This new R-factor is higher than in the
old structure, but more in line with what is expected from
2.5 Å data (35). The new structure was analyzed with
PROCHECK (38) and WHATCHECK (39), and had im-
proved stereochemistry compared to the old model (see Table
1).
RESULTS AND DISCUSSION
Kinetic Analysis of ActiVe Site Mutants of CGTase Using
Glycosyl Fluorides as Substrates. As reported previously,
both RG3F and RGF are convenient substrates for CGTase
since the enzyme-catalyzed release of fluoride can be easily
assayed using an ion-selective fluoride electrode (31). Even
though CGTase otherwise prefers longer oligosaccharides,
a short one, such as RGF, can be used if a good leaving
group, such as fluoride, is provided. When the release of
fluoride from RGF is followed using the fluoride electrode,
a low reaction rate is observed over a lengthy induction
period, but this rate gradually increases with time in an
apparently sigmoidal manner, as is shown in Figure 3. It
seemed likely that this behavior was a consequence of a
transglycosylation reaction between two molecules of RGF
Table 1: Quality of the Old and Re-refined CGTase + Acarbose
Models
old (1cxg)
(16)
re-refined
(cross-validated)
(2cxg)
refinement statistics
no. of nonsolvent atoms 5379 5401
no. of solvent atoms 192 92
average B factor (Å2) 20.5 14.7
final R factor (%)a 15.1 18.2
final free R factor (%)b - 23.7
Ramachandran outliers 0 0
coord error Luzzati (Å) (47)c 0.20 0.26
coord error óA (Å) (44)c 0.22 0.25
Procheck G factor (38)d -0.47 0.17
root mean square deviation from ideal geometry
bond lengths (Å) 0.011 0.004
bond angles (deg) 2.3 1.147
torsion angles (deg) 15.9 18.245
trigonal planes (Å) 0.015 0.004
planar groups (Å) 0.012 0.007
van der Waals contacts (Å) 0.028 0.009
neighboring atom B factor
correlations (Å2)
2.88 1.29
a R factor ) ªhjFo - Fcj/ªhFo where Fo and Fc are the observed and
calculated structure factor amplitudes of reflection h, respectively.
Reflections between 8.0 and 2.5 were used, with bulk solvent correction
as implemented in TNT (36). The low R-factor of the old structure
might indicate over refinement (35). b The free R factor is calculated
as the R factor, using Fo that were excluded from the refinement.
c Including all atoms. The error models are R factor based, which could
explain the higher errors in the cross-validated structure. d A high value
of the G factor indicates good overall stereochemistry.
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acceptor, thereby more rapidly reacting to give RG3F and
so on. The lack of such an induction period when RG3F
was used as substrate (data not shown) certainly supports
this hypothesis. Further evidence that longer oligosaccha-
rides serve as better acceptors was obtained by monitoring
the reaction with RGF in the presence of different malto-
oligosaccharides. As seen in Figure 3, inclusion of malto-
triose considerably shortens the lag period while maltotet-
raose shortens it yet further. When maltopentaose or
maltohexaose was added, no lag phase at all was observed.
Since, in this study, we were interested in the rates of reaction
of RGF, only the initial slope was used in our kinetic
evaluation.
As shown in Table 2, a wide variety of mutations within
the active site has been generated in an effort to determine
the effect that a particular alteration has on the enzyme-
catalyzed reaction. All of the mutants tested were able to
utilize RG3F as a substrate, albeit to varying extents, with
kcat values ranging from 275 to 0.0093 s-1, a spread of almost
(3  104)-fold. Interestingly, Km values for all the mutants
studied were greater than that for the wild-type enzyme,
indicating varying degrees of disruption of binding interac-
tions. Consequently, kcat/Km values varied over an even
larger range with a spread of (4.8  105)-fold. The degree
of weakening of binding ranged from very small (<2-fold)
in the cases of theY195F and S145E mutants to very large
(80-fold) in the case of the Y195G mutant. This very small
effect with the S145E mutant is consistent with the observa-
tion that this residue interacts only with the sugar residue in
the -7 site (26). RG3F will not bind in that site; thus, effects
should be minimal. The presence of very disparate effects
with the Y195F and Y195G mutants is also consistent with
the role of Y195. Y195 is thought to be the key amino acid
in the active site which the cyclodextrin product wraps
around during formation. It may also be largely responsible
for helping to exclude water molecules from the active site,
thus preventing hydrolysis (26). Its hydroxyl group is
thought to hydrogen bond to the sugar in the +1 site, while
the aromatic ring provides important interactions with the
rest of the substrate, especially the sugar in the -1 site (26).
Since RG3F does not occupy the +1 site, minor conse-
quences of removing that hydrogen bond are reasonable, yet
complete removal of the side chain is clearly highly
deleterious.
Mutations within the CGTase system produced an even
larger range of effects on the enzyme-catalyzed reaction of
the shorter, monosaccharide substrate RGF; the kcat values
spanned from 330 to 0.0002 s-1, a range of (1.6  106)-fold
(Table 2). Effects on Km ranged from a small disruption in
binding (<1.5-fold) for the Y195F mutant to significant
changes in binding (25-fold) for the Y195G mutant. Effects
on kcat/Km consequently ranged over (4.1  107)-fold.
Similar structure/activity correlations to those observed with
RG3F are apparent. That is, the proximity of Y195 and N326
to the -1 subsite make them important residues for optimal
binding of the substrate. N326 is known to sit in a key
position in the active site, and kinetic analysis on mutants
modified at the equivalent residue in a thermostable CGTase
showed drastic changes in pH optima upon mutation (30).
Therefore, mutations at these positions result in the largest
disruptions in binding affinity and rate reductions.
Since this enzyme is a transferase, therefore ultimately
requiring interactions in both the glycone and aglycone sites,
care must be exercised in the interpretation of the kinetic
parameters of these various mutants in terms of localized
binding interactions. This is particularly true when the rate-
determining step for each substrate/mutant combination is
not known. If formation of the glycosyl enzyme is rate-
limiting, then interactions in the negative (-1, -2, etc.) sites
will likely be the most important. If, however, the second,
transglycosylation step is rate-limiting, then interaction with
the positive (+1, +2, etc.) sites could be equally important.
This uncertainty is largely sidestepped if values of kcat/Km
are interpreted since this second-order rate constant, known
as the specificity constant, reflects only the first irreversible
step. For CGTase utilizing glycosyl fluoride substrates, as
shown with various glycosidases (40-42), it is reasonable
to assume that this is the first, glycosylation step; thus,
changes in kcat/Km reflect changes in interactions in the
negative sites.
Inhibition of CGTase Mutants by Acarbose. Inhibition
constants for acarbose were measured with each of the
CGTase mutants, and these are also presented in Table 2. In
three cases, including the weakest and strongest binding
examples, the Ki value was determined from a full analysis
using a range of substrate and inhibitor concentrations as is
shown for Y195G CGTase in Figure 4. Inhibition was
strictly competitive in each case. In the other cases, Ki values
were determined from data obtained at a series of inhibitor
concentrations using a fixed concentration of substrate as
described under Materials and Methods. The mutant en-
zymes all bound to acarbose, but less tightly than does wild-
type CGTase, with widely varying affinities ranging from a
Ki of 0.2 íM for wild type to 341 íM for Y195G CGTase.
This large loss of affinity upon removal of the Y195 side
chain is again consistent with the key role played by this
residue.
FIGURE 3: Reaction of D371N CGTase with RGF (28 mM) and
various acceptors showing fluoride release over time. Concentrations
of acceptors used were: O ) no added acceptor; b ) 30 mM G3;
0 ) 30 mM G4; 9 ) 30 mM G5; 4 ) 30 mM G6. Inset graph
(expansion of main figure): O ) no added acceptor; 2 ) 30 mM
G; 3 ) 30 mM G2. The data for G and G2 have been displaced
0.36 mM above the actual initial concentration of fluoride to allow
for easier visualization of the results.
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Acarbose? Some measure of the degree to which acarbose
mimics the reaction transition state is provided by the plot
of log (Km/kcat) for RG3F versus log Ki for acarbose in Figure
5A. A respectable correlation (r ) 0.90) is observed with a
slope of 1.61 (solid line, all data points), clearly indicating
a substantial degree of mimicry. Changes in binding
interactions to the inhibitor therefore correlate quite well with
changes in transition state binding interactions with substrate.
Not surprisingly, there is also some mimicry of ground-state
binding interactions as revealed by the correlation of log Km
for the substrate RG3F with log Ki for acarbose (Figure 6A).
A correlation coefficient of r ) 0.90 is again observed, but
the slope, 0.47, is approximately 3 times smaller than that
with log (Km/kcat).
Interestingly, the correlation seen between Ki for acarbose
and Km/kcat for RGF is considerably better, with r ) 0.98
and a slope of 2.2, as shown in Figure 5B. This very strong
correlation clearly indicates that acarbose has properties of
a transition state analogue. Again, some ground-state
mimicry was observed, the plot of log Km versus log Ki for
acarbose having a slope of 0.4 and r ) 0.93 (Figure 6B). A
better indication of the relative qualities of these two fits is
obtained from the coefficient of determination, r2. For the
Km/kcat plot, the r2 value is 0.96, meaning that 96% of the
points are well described by the line, whereas for the Km
plot the r2 value is 0.86, meaning that only 86% of the points
are well fit. The better correlation observed for RGF than
RG3F is completely consistent with the binding modes of
these substrates and of acarbose, as shown in Figure 1. The
only occupied subsite common to the substrates and to
acarbose is, in fact, the -1 subsite, assuming that acarbose
binds in that mode. Thus, the effects of mutations upon
interactions at that site will dominate the correlation. Such
effects will be particularly large if the mutation directly
removes interactions at that site. In addition, changes in
interactions at that site resulting from more remote mutations
will also be sensed. However, mutations at more remote
sites which do not have an effect upon interactions at that
site will not be sensed. Thus, mutations affecting only
interactions at the +1, +2, and +3 sites will affect the
binding of acarbose but will not necessarily affect Km/kcat
Table 2: Kinetic Parameters for the Reaction of R-Glucosyl Fluoride and R-Maltotriosyl Fluoride with CGTases (wt and Mutants) and for
Inhibition by Acarbose
R-glucosyl fluoride R-maltotriosyl fluoride
CGTase Km (mM) kcat(s-1) kcat/Km(s-1 mM-1) Km(mM) kcat(s-1) kcat/Km(s-1 mM-1) acarbose Ki(mM)
wt 32.3a 330a 10.2a 2.5a 275a 110a 0.0002
Y195F 40.0 123 3.075 4.0 7.8 1.95 0.00036
Y195L 100 0.60 0.006 11.6 0.47 0.041 0.0176
Y195G 800 2  10-4 2.5  10-7 200 0.046 0.00023 0.341
N326Q 400 4.8  10-3 1.2  10-5 12.2 0.0093 0.00076 0.106
S145E 60 100 1.67 3.37 175 51.9 0.001
S146P 250 0.16 6.4  10-4 16.5 7.75 0.470 0.025
D371N 74 1.35 0.0182 18.6 214 11.5 0.010
N193G 50 0.54 0.0108 7.65 57.6 7.52 0.005
a Reported previously (31).
FIGURE 4: Lineweaver-Burk plot for Y195G CGTase with RG3F
as substrate and acarbose as inhibitor. Concentrations of acarbose
used were: O ) 0 íM; b ) 38 íM; 4 ) 200 íM; 2 ) 384 íM;
0 ) 770 íM.
FIGURE 5: Linear free energy relationship between kinetic param-
eters for the inhibitor acarbose and glycosyl fluoride substrates with
a series of mutants of CGTase. (A) log (Km/kcat) for RG3F vs log
Ki for acarbose; (B) log (Km/kcat) for RGF vs log Ki for acarbose.
(Filled circles represent Tyr mutants. The grey shaded circle
represents wild-type CGTase. The dashed line indicates the best
fit line through Y195 mutants and wt. The solid line is the best fit
line through all the data.)
FIGURE 6: Linear free energy relationship between kinetic param-
eters for the inhibitor acarbose and glycosyl fluoride substrates with
a series of mutants of CGTase. (A) log Km for RG3F vs log Ki for
acarbose; (B) log Km for RGF vs log Ki for acarbose. (Filled circles
represent Tyr mutants. The grey shaded circle represents wild-
type CGTase. The dashed line indicates the best fit line through
Y195 mutants and wt. The solid line is the best fit line through all
the data.)
17196 Biochemistry, Vol. 37, No. 49, 1998 Mosi et al.values for the two substrates. This will result in scatter in
the plots shown (Figure 5A). Similarly, mutations affecting
interactions in the -2 and -3 sites will affect Km/kcat values
for RG3F, but not Ki values for acarbose, thus adding
additional scatter to that correlation. The -2 and -3 sites
are not directly probed by RGF, hence the improved
correlation.
Another measure of the importance of probing equivalent
interactions with the substrate and with the inhibitor is
obtained by selecting data only for mutants in which
interactions at the common (-1) subsite are directly affected.
The only amino acid residue mutated which fully fits that
requirement is Tyr195. Indeed, as shown with the filled
circles in Figure 5A, when only such data are considered a
much better correlation (r ) 0.97, slope ) 1.55, linear fit
displayed as a dashed line) is observed, consistent with the
interactions observed crystallographically.
It is instructive to consider the true meaning of the slopes
of these linear free energy relationships, which compare
inhibitor binding free energies with activation free energies
for the reaction, mutant by mutant. A slope of 1.0 would
indicate optimal transition state mimicry since this would
indicate that mutations cause equal changes in the binding
of the transition state analogue and the transition state itself.
Any slope greater or smaller than this would indicate a lesser
degree of mimicry. It is not, however, clear that a slope of
1.0 is required to indicate any degree of mimicry as has been
suggested (9), a conclusion that was developed on the
assumption of direct proportionality of rate constants and
equilibrium constants themselves. The slopes observed for
the Km/kcat plots (1.6-2.2) are therefore approximately
equally dissimilar to those observed for the Km plots (a factor
of 2 in each case), perhaps indicating equal mimicry of the
ground state and transition state. However it is also quite
possible that the large slope in the Km/kcat plot reflects the
fact that acarbose has three sugar residues bound in the +1,
+2, and +3 sites which are not occupied in the substrate
case. This may well have the effect of immobilizing the
valienamine moiety at the active site to a greater extent than
is the case for the monosaccharide transition state. A
consequence of this could be a greater effect of specific
mutations on the binding of this valienamine moiety than
on the stabilization of the transition state for glucosyl transfer,
hence a slope greater than 1.
Crystallographic Re-refinement. In light of the results
presented here which confirm that acarbose has significant
transition state analogue character, the binding mode of
acarbose to CGTase was reexamined using the original data
set as described under Materials and Methods. This is
particularly important since, at the time of publication of
the first structure (16), it was not realized that acarbose may
undergo a transglycosylation reaction in the crystal, adding
a glucose residue to the valienamine (26). The refined
structure presented contains all 686 amino acids, 2 Ca2+ ions,
1 rearranged acarbose inhibitor, and maltose residues at
binding sites (MBS) 1 and 3. At MBS2, originally a maltose
was modeled in this position (16), but upon refinement,
electron density corresponding to four glucose residues was
noted. The coordinates of this structure (2cxg) will be
submitted to the PDB. The coordinates of an acarbose-
derived maltononaose inhibitor bound to CGTase (1dij) (26)
will also be resubmitted (2dij), since in this instance the
valienamine is also modeled at subsite -2 and the 6-deoxy-
glucose at subsite -1.
To reexamine the binding mode of acarbose, the electron
density maps were calculated using structures refined with
the carbohydrate O6 atoms set to zero occupancy. The
OMIT (43) and SIGMAA (44) procedures were used to
minimize model bias. The overall statistics (Table 1) show
that the old and new structures have a comparable fit to the
crystallographic data. However, the electron density calcu-
lated after minimizing the refinement bias clearly showed
sugar 6-hydroxyl groups at subsites -2, -1, and +2,
contradicting the presence of a 6-deoxyglucoside at the -1
site, as originally modeled (Figure 7) (16). At subsite +1,
electron density for a 6-hydroxyl group is absent. This
conclusion was further supported by a 2.2 Å resolution data
set from a CGTase I145 mutant complexed to acarbose in
which the valienamine moiety was also observed to bind at
the -1 subsite (R. Ruiterkamp, unpublished results). There-
fore, the 6-deoxyglucose unit of acarbose was modeled into
the +1 subsite, and the valienamine unit (which has a
6-hydroxyl group) was modeled into subsite -1, correspond-
ing to the orientation found in R-amylases and other
CGTases.
On the basis of this re-refined structure, it is of interest to
consider the interactions between the protein and the vali-
enamine moiety in the -1 site that might be responsible for
this strong correlation, hence for stabilization of the normal
transition state. Probably of primary importance are the
hydrogen bonding interactions (3.3 and 2.9 Å, respectively)
between OE1 and OE2 of Glu257, the acid/base catalyst,
and the NH group of the valienamine. Also of importance,
especially given the ring flattening that must occur during
catalysis, are the interactions between Asp328 (OD2) and
O2 of the valienamine (2.7 Å) as well as between Asp328
(OD1) and O3 of the valienamine (3.2 Å). Other interactions
are between His327 (NE2) and both O2 and O3 of the
valienamine (3.1 and 3.0 Å, respectively), and between
His140 and O6. Interesting stacking interactions also appear
to exist between the double bond of the valienamine moiety
and the aromatic ring of Tyr100. This substantial network
of interactions presumably provides the stabilization needed
at the transition state and for binding of this analogue.
Conclusions. The excellent correlation seen between log
(Km/kcat) for hydrolysis of RGF by a series of CGTase
FIGURE 7: Electron density for a rearranged acarbose from the re-
refined data set. An arrow indicates the 6-hydroxyl group of the
valienamine moiety.
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mutants provides good evidence that acarbose functions, at
least in part, as a transition state analogue inhibitor for this
enzyme. It seems probable that the majority of the binding
interactions providing this high affinity are associated with
the valienamine moiety. Since acarbose also contains a
trisaccharide portion, it is not surprising that it also exhibits
ground-state mimicry as revealed in the plot of log Km versus
log Ki. These results are consistent with expectations
regarding the structure of the transition state for this retaining
transferase. It is also of importance to note that a similar
correlation was recently observed for the inverting R-gly-
cosidase, glucoamylase (15). These results therefore provide
further support for the notion that transition states for
inverting and retaining glycosidases are quite similar in
character (45, 46). This study also provides a clear example
of how detailed kinetic analysis can provide a critical
assessment of published crystallographic data resulting in
reevaluation of the structural results.
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